SCHEMBL8965867

SCHEMBL8965867

Cc1cc(COc2ccc(N)nn2)cc(C)c1C

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.38
BCAT2 O15382 1/20 0.38
ALDH1A1 P00352 1/20 0.37
GAA P10253 2/20 0.37
NUDT1 P36639 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
HDAC1 Q13547 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HDAC5 Q9UQL6 1/20 0.32
TP53 P04637 1/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
PDE2A O00408 1/20 0.31
NOS3 P29474 2/20 0.31
NOS1 P29475 2/20 0.31
ENPP2 Q13822 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8965593 0.79 NOS1 (0.45) BCAT2ALDH1A1PDE2ANOS3NOS1
SCHEMBL8965946 0.78 IDO1 (0.51) FFAR1ALDH1A1LMNA
SCHEMBL8965857 0.78 NUDT1 (0.43) FFAR1BCAT2ALDH1A1GAANUDT1
SCHEMBL8965564 0.77 TUBB1 (0.48) ALDH1A1
SCHEMBL933699 0.76 BCAT2 (0.55) BCAT2ALDH1A1GAANUDT1LMNA
SCHEMBL8965617 0.75 TAAR1 (0.41) BCAT2ALDH1A1HTTPOLBMAPT
SCHEMBL10533393 0.74 NPC1 (0.50) BCAT2ALDH1A1LMNAHTTPOLB
SCHEMBL8966307 0.74 HTR2A (0.49) GAALMNAMAPT
SCHEMBL8965939 0.73 MAOB (0.55) HTTMAPT
SCHEMBL8965693 0.72 CYP3A4 (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5538970-A Treatment of cancer with imidazo-1,2-pyridazin compounds GLAXO WELLCOME INC. (US) 1996-07-23 US disclosed
US-5447956-A Anticarcinogenic agents BURROUGHS WELLCOME CO. (US) 1995-09-05 US disclosed
US-5380759-A Methyl N-[6-(3,4,5-trimethoxybenzloxy)imidazo[1,2-b]pyridazin-2-zyl]carbamate used to treat leukemia BURROUGHS WELLCOME CO. (US) 1995-01-10 US disclosed
US-5371219-A Antitumor agents BURROUGHS WELLCOME CO. (US) 1994-12-06 US disclosed
EP-0305093-B1 Imidazo(1,2-b)pyridazine derivatives WELLCOME FOUND (GB) 1994-04-06 EP disclosed
US-5091531-A Antitumor agents BURROUGHS WELLCOME CO. (US) 1992-02-25 US disclosed
EP-0305093-A1 Imidazo(1,2-b)pyridazine derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1989-03-01 EP disclosed